Search results for "Hepatocellular carcinoma"
Spotlight on hepatitis A, B, and C
The past month's gastroenterology research may not have been simple as ABC, but it did focus on the major types of hepatitis, including a hepatitis A outbreak, a comparison of hepatitis B drugs, and new data on hepatitis C complications and incidence.
https://gastroenterology.acponline.org/archives/2019/10/25/5.htm
25 Oct 2019
Lipophilic statins associated with significantly reduced hepatocellular carcinoma incidence, mortality in hepatitis
Potential benefits of lipophilic statins appeared to be dose- and duration-dependent, with the greatest reduction in hepatocellular carcinoma risk seen with use of a moderate-dose statin for about two years, according to data from a registry of Swedish patients with hepatitis B or C.
https://gastroenterology.acponline.org/archives/2019/08/23/7.htm
23 Aug 2019
In compensated cirrhosis with portal hypertension, beta-blockers reduced a composite of decompensation or death
The trial results cannot be generalized to all patients with cirrhosis, and future trials should look at whether similar effects could be achieved simply by limiting salt intake, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2019/08/23/10.htm
23 Aug 2019
Spotlight on new guidelines
The American Association for the Study of Liver Diseases, the American Gastroenterological Association, the American College of Gastroenterology, and the U.S. Preventive Services Task Force all released new guidelines this month.
https://gastroenterology.acponline.org/archives/2019/07/26/5.htm
26 Jul 2019
MKSAP quiz: HCV-related cirrhosis with decompensation
This month's quiz asks readers to determine the next step in management for a 64-year-old man with hepatitis C virus (HCV)-related decompensation.
https://gastroenterology.acponline.org/archives/2019/03/22/4.htm
22 Mar 2019
Daily aspirin may reduce risk of hepatitis-related liver cancer
A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.
https://gastroenterology.acponline.org/archives/2019/03/22/1.htm
22 Mar 2019
Spotlight on direct-acting antivirals
Studies of contemporary populations with hepatitis C virus infection demonstrated that treatment with direct-acting antiviral therapies was linked to improvement in several long-term clinical outcomes.
https://gastroenterology.acponline.org/archives/2019/02/22/5.htm
22 Feb 2019
Statins associated with reduced mortality risk in hepatocellular carcinoma
Inverse associations between postdiagnosis statin use and cancer-specific and all-cause mortality were consistent for low- and high-dose statins and for a range of time periods after cancer diagnosis.
https://gastroenterology.acponline.org/archives/2019/01/25/2.htm
25 Jan 2019
More liver transplants occurring in patients with alcohol-associated liver disease
The increase from 2002 to 2016 can partly be explained by reductions in hepatitis C-related transplants but may also indicate changing perspectives on abstinence requirements, study authors said.
https://gastroenterology.acponline.org/archives/2019/01/25/4.htm
25 Jan 2019
Spotlight on mortality trends in liver disease
One study looked at 10-year U.S. mortality trends related to chronic liver diseases, while another assessed mortality from cirrhosis and liver cancer in the U.S. from 1999 to 2016.
https://gastroenterology.acponline.org/archives/2018/07/27/5.htm
27 Jul 2018